论文部分内容阅读
Background Studies have shown that miRNA-155 played an important role in the process of development of hypertension.However,there is no date about miRNA-155 and blood pressure monitoring parameters.Therefore,we examined whether in hypertensive patients the expression level of plasma miRNA-155 related to 24-h ambulatory blood pressure monitoring (ABPM) parameters.Methods A cohort of adult patients scheduled to receive physical examination,office and ambulatory blood pressure monitoring.Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was used to evaluate the expression of selected miRNA-155.The miRNA-155 expression level correlation between blood pressure parameters was assessed using the Spearman correlation coefficient.Results Fifty four essential hypertension patients (25 men;mean age,53.28 ± 9.52 years) and thirty healthy volunteers (15 men;mean age,53.03 ± 5.87 years) were included.We observed higher expression level of miRNA-155 (32.31 ± 2.85 vs 27.21 ± 1.59,P ＜ 0.001) in hypertensive patients compared to healthy control individuals.MiRNA-155 expression level showed significant positive correlation with 24 h Daytime SBP (r =0.681,P ＜ 0.001),24 h Daytime DBP (r =0.473,P ＜ 0.001),24 h Daytime PP (r =0.565,P ＜ 0.001) and dipping (r =0.257,P =0.018),respectively.Conclusions Our study showed that miRNA-155 expression level was associated positively with daytime blood pressure monitoring parameters,as well as blood pressure variability,indicating a possible implication of miRNA-155 in the pathogenesis of hypertension.